Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.2B | 5.0B | 4.2B |
Cost of revenue | 1.4B | 1.5B | 1.8B | 1.5B |
Gross profit | 3.0B | 2.7B | 3.2B | 2.7B |
Operating expense | ||||
Research & development | 495.1M | 514.8M | 505.1M | 494.3M |
Selling general and admin | 1.8B | 1.6B | 1.8B | 1.8B |
Other operating expenses | — | — | — | — |
Operating income | 774.3M | 568.7M | 901.5M | 503.9M |
Non operating interest income | ||||
Income | 49.1M | 41.0M | 46.8M | 53.1M |
Expense | 73.8M | 35.3M | 60.3M | 36.6M |
Other income expense | — | — | — | — |
Pretax income | 805.1M | 451.0M | 955.3M | 539.1M |
Tax provision | 126.6M | 95.6M | 152.1M | 109.8M |
Net income | 678.5M | 355.4M | 803.2M | 429.3M |
Basic EPS | 0.3 | 0.2 | 0.3 | 0.2 |
Diluted EPS | 0.3 | 0.2 | 0.3 | 0.2 |
Basic average shares | 2.3B | 2.3B | 2.3B | 2.3B |
Diluted average shares | 2.3B | 2.3B | 2.3B | 2.3B |
EBITDA | 866.8M | 523.0M | 972.2M | 535.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | -9.6M | -4.6M | -10.1M | 4.4M |
Preferred stock dividends | 0 | 0 | 0 | 0 |